This inventor holds 1 USPTO granted patent. Top assignee: Daewoong Pharmaceutical Co., Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Myung-gi Jung: Innovator in Pharmaceutical Chemistry
Introduction
Myung-gi Jung is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of heterocyclic compounds. His work focuses on addressing diseases linked to abnormalities in prolyl-tRNA synthetase activity.
Latest Patents
Myung-gi Jung holds a patent for a heterocyclic compound, its preparation method, and a pharmaceutical composition comprising the same. This invention is represented by Chemical Formula 1 and is aimed at preventing or treating diseases caused by irregularities in PRS activity. The patent highlights the potential of this compound and its pharmaceutically acceptable salts in medical applications.
Career Highlights
Jung is currently associated with Daewoong Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His expertise in chemical compounds has positioned him as a valuable asset in the research and development of new therapeutic solutions.
Collaborations
Throughout his career, Myung-gi Jung has collaborated with esteemed colleagues, including Bong-Yong Lee and Min-Jae Cho. These partnerships have fostered a collaborative environment that enhances the innovation process within the company.
Conclusion
Myung-gi Jung's contributions to pharmaceutical chemistry, particularly through his patented innovations, underscore his role as a leading inventor in the field. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile